Skip to main content

Table 4 Univariate analysis according to the genotyping of vascular endothelial growth factor

From: The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer

Genotype

Polymorphism

No. of patients

PFS (Mo)

P*

OS (Mo)

P*

−2578C/A

CC

116

4.9

0.676

12.8

0.423

 

CA

63

3.9

 

14.4

 
 

AA

11

3.0

 

11.5

 

−2489C/T

CC

116

4.9

0.249

12.8

0.462

 

CT

60

4.0

 

14.4

 
 

TT

14

2.9

 

11.5

 

−1498 T/C

TT

116

4.9

0.647

12.8

0.440

 

TC

61

3.9

 

13.7

 
 

CC

13

3.0

 

11.8

 

−634 G/C

GG

54

3.5

0.043

13.1

0.407

 

GC

93

4.8

 

14.4

 
 

CC

43

4.9

 

11.5

 

+936C/T

CC

135

4.5

0.925

13.1

0.711

 

CT

45

4.7

 

11.9

 
 

TT

10

3.9

 

11.9

 

+1612 G/A

GG

139

4.4

0.448

12.8

0.644

 

GA

47

5.0

 

14.4

 
 

AA

4

2.1

 

10.6

 
  1. *by log-rank test.
  2. PFS: progression free survival, Mo: months, OS: overall survival.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us